Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis

Journal of Lipid Research

Volumn 44, Issue 1, 2003, Pages 93-102

  Okamoto, Reiko ^a   Arikawa, Junko ^a   Ishibashi, Mutsumi ^a   Kawashima, Makoto ^a   Takagi, Yutaka ^b   Imokawa, Genji ^a,b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Kao Biological Science Laboratories   (Japan)

Author keywords

Barrier disruption; Ceramide deficiency; Sphingomyelin deacylase

Indexed keywords

ACETIC ANHYDRIDE; ACYLSPHINGOSINE DEACYLASE; AMIDASE; CARBON 14; CERAMIDE; GLUCOSYLCERAMIDE; GLUCOSYLCERAMIDE DEACYLASE; GLUCOSYLSPHINGOSINE; LYSOSPHINGOLIPID; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN DEACYLASE; SPHINGOSYLPHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRATUM CORNEUM; THIN LAYER CHROMATOGRAPHY; UPREGULATION;

ADOLESCENT; ADULT; CERAMIDES; DERMATITIS, ATOPIC; EPIDERMIS; HUMANS; PHOSPHORYLCHOLINE; PSYCHOSINE; SPHINGOSINE; UP-REGULATION;

EID: 0037243004     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200225-JLR200     Document Type: Article

References (25)

1. Imokawa, G., and M. Hattori. 1985. A possible function of structural lipid in the water-holding properties of the stratum corneum. J. Invest. Dermatol. 84: 282-284.
2. Imokawa, G., H. Kuno, and M. Kawai. 1991. Stratum corneum lipids serve as a bound-water modulator. J. Invest. Dermatol. 96: 845- 851.
3. Holleran, W. M., M. Mao-Qiang, W. N. Gao, G. K. Menon, P. M. Elias, and K. R. Feingold. 1991. Sphingolipids are required for mammalian epidermal barrier function, inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J. Clin. Invest. 88: 1338-1345.
4. Imokawa, G., Y. Yada, K. Higuchi, M. Okuda, Y. Ohashi, and A. Kawamata. 1994. Pseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid deficient rats and has an inhibitory effect on epidermal hyperplasia. J. Clin. Invest. 94: 89-96.
5. Imokawa, G., A. Abe, K. Jin, Y. Higaki, M. Kawashima, and A. Hidano. 1991. Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J. Invest. Dermatol. 96: 523-526.
6. Murata, Y., J. Ogata, Y. Higaki, M. Kawashima, Y. Yada, K. Higuchi, T. Tsuchiya, S. Kawaminami, and G. Imokawa. 1996. Abnormal expression of sphingomyelin acylase in atopic dermatitis: An etiologic factor for ceramide deficiency? J. Invest. Dermatol. 106: 1242-1249.
7. Hara, J., K. Higuchi, R. Okamoto, M. Kawashima, and G. Imokawa. 2000. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J. Invest. Dermatol. 115: 406-413.
8. Hanifin, J. M., and G. Rajka. 1989. Diagnostic features of atopic dermatitis. Acta. Derm. Venereol. (Stockh). 92: 44-47.
9. 4 Cer. J. Biochem. 105: 829-833.
10. Yatomi, Y., F. Ruan, J. Ohta, R. J. Welch, S. Hakomori, and Y. Igarashi. 1995. Quantitative measurement of sphingosine 1-phosphate in biological samples by acylation with radioactive acetic anhydride. Anal. Biochem. 230: 315-320.
11. Arikawa, J., M. Ishibashi, M. Kawashima, Y. Takagi, Y. Ichikawa, and G. Imokawa. 2002. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J. Invest. Dermatol. 119: 433-439.
12. Ishibashi, M., J. Arikawa, R. Okamoto, M. Kawashima, Y. Takagi, K. Oguchi, and G. Imokawa. 2001. Physiological relevance of another hitherto undiscovered epidermal enzyme, glucosylceramide deacylase to acylceramide deficiency in atopic dermatitis (Abstract). Jpn. J. Dermatol. 111: 413.
13. Rawlings, A. V., A. Davies, M. Carlomusto, S. Pillai, K. Zhang, R. Kosturko, P. Verdejo, C. Feinberg, L. Nguyen, and P. Chandar. 1996. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch. Dermatol. Res. 288: 383-390.
14. Desai, N. N., R. O. Carlson, M. E. Mattie, A. Olivera, N. E. Buckley, T. Seki, G. Brooker, and S. Spiegel. 1993. Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. J. Cell Biol. 121: 1385-1395.
15. Ito, M., T. Kurita, and K. Kita. 1995. A novel enzyme that cleaves the N-acyl linkage of ceramides in various glycosphingolipids as well as sphingomyelin to produce their lyso forms. J. Biol. Chem. 270: 24370-24374.
16. Higuchi, K., J. Hara, R. Okamoto, M. Kawashima, and G. Imokawa. 2000. The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem. J. 350: 747-756.
17. Schmuth, M., M. Q. Man, F. Weber, W. Gao, K. R. Feingold, P. Fritsch, P. M. Elias, and W. M. Holleran. 2000. Permeability barrier disorder in Niemann-Pick Disease: Sphingomyelin-ceramide processing required for normal barrier homeostasis. J. Invest. Dermatol. 115: 459-466.
18. Orbisky, E., E. Sidransky, C. E. McKinney, M. E. Lamarca, R. Samimi, D. Krasnewich, B. M. Martin, and E. I Ginns. 2000. Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. Pediatr. Res. 48: 233-237.
19. Kanazawa, T., S. Nakamura, M. Momoi, T. Yamaji, H. Takematsu, H. Yano, H. Sabe, A. Yamanoto, T. Kawasaki, and Y. Kozutsumi. 2000. Inhibition of cytokinesis by a lipid metabolite, psychosine. J. Cell Biol. 149: 943-950.
20. Atsumi, S., C. Nosaka, H. Iinuma, and K. Umezawa. 1993. Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol. Arch. Biochem. Biophys. 304: 302-304.
21. Holleran, W. M., E. I. Ginns, G. K. Menon, J. U. Grundmann, M. Fartasch, C. E. McKinney, P. M. Elias, and E. Sidransky. 1994. Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J. Clin. Invest. 93: 1756-1764.
22. Bibel, D. J., A. Raza, and H. R. Shinefield. 1992. Antimicrobial activity of sphingosines. J. Invest. Dermatol. 98: 269-273.
23. Imokawa, G., Y. Takagi, K. Higuichi, H. Kondo, and Y. Yada. 1999. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. J. Invest. Dermatol. 112: 91-96.
24. Higuchi, K., M. Kawashima, Y. Takagi, H. Kondo, Y. Yada, Y. Ichikawa, and G. Imokawa. 2001. Sphingosylphosphorylcholine is an activator of transglutaminase activity in human keratinocytes. J. Lipid Res. 42: 1562-1570.
25. Higuchi, K., M. Kawashima, Y. Ichikawa, and G. Imokawa. 2001. Effects of sphingosylphosphorylcholine on proliferation and melanogenesis in human melanocytes (Abstract). Pigmet Cell Res. 14: 53.